Wakamoto
4512.TWakamoto Pharmaceutical Co.,Ltd. Price (4512.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
34,706,000
(0.0029)%Revenue and Profitability
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10,181,164,000 | 10,081,276,000 | 9,779,708,000 | 9,671,815,000 | 9,429,946,000 | 9,924,168,000 | 10,314,297,000 | 10,613,425,000 | 11,194,262,000 | 10,833,025,000 | 10,900,874,000 | 10,741,975,000 | 10,917,899,000 | 8,894,837,000 | 8,383,144,000 | 8,660,377,000 | 7,738,426,000 |
| Net Income | 406,893,000 | 351,361,000 | 48,518,000 | -425,505,000 | -222,170,000 | 183,344,000 | 844,791,000 | 83,343,000 | 20,512,000 | 94,745,000 | 125,956,000 | -181,280,000 | -1,656,539,000 | -601,856,000 | 238,543,000 | 138,256,000 | 108,959,000 |
| FCF USD | 236,129,000 | -1,002,348,000 | -2,137,969,000 | -131,218,000 | -137,392,000 | 652,889,000 | 892,437,000 | -65,139,000 | 111,683,000 | 749,747,000 | 129,662,000 | -710,814,000 | -362,324,000 | -318,817,000 | -28,967,000 | 420,757,000 | -663,024,000 |
| OCF USD | 894,171,000 | 824,582,000 | 489,390,000 | 346,513,000 | 589,256,000 | 1,199,890,000 | 1,629,172,000 | 1,175,302,000 | 594,303,000 | 1,098,285,000 | 555,706,000 | -114,493,000 | -155,064,000 | 163,438,000 | 339,174,000 | 631,920,000 | -107,338,000 |
Financial Health - DEBT
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 10.11 | -1.96 | -10.46 | 2.46 | 0.16 | -2.70 | 2.95 | 1.23 | 0.26 | -0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| D/E | 0.00 | 0.00 | 0.13 | 0.12 | 0.14 | 0.15 | 0.11 | 0.10 | 0.08 | 0.05 | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
| CA/CL | 4.15 | 2.69 | 3.75 | 3.56 | 4.29 | 3.96 | 2.49 | 3.63 | 3.72 | 3.97 | 4.10 | 3.55 | 3.55 | 4.46 | 4.29 | 4.18 | 4.96 |
| TA/TL | 4.03 | 3.56 | 3.52 | 3.43 | 3.55 | 3.57 | 3.27 | 3.91 | 4.22 | 4.48 | 4.67 | 4.44 | 3.96 | 4.57 | 4.31 | 4.13 | 4.54 |
| Total Debt | 0 | 29,064,000 | 1,650,869,000 | 1,471,076,000 | 1,657,842,000 | 1,860,991,000 | 1,553,865,000 | 1,358,529,000 | 1,108,946,000 | 751,326,000 | 338,010,000 | 188,203,000 | 165,439,000 | 171,200,000 | 129,138,000 | 137,793,000 | 130,732,000 |
Management Performance
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 2.35% | 0.81% | -0.10% | -3.41% | -5.71% | 0.05% | 0.46% | 0.22% | 0.08% | 0.31% | -0.34% | -2.02% | -13.21% | -4.96% | -0.09% | 0.68% | -0.98% |
| ROE | 3.16% | 2.75% | 0.38% | -3.50% | -1.84% | 1.45% | 6.12% | 0.59% | 0.15% | 0.68% | 0.89% | -1.32% | -13.87% | -5.29% | 2.08% | 1.16% | 0.91% |
| ROA | 0.00% | 3.42% | 0.80% | -3.65% | -0.76% | 2.56% | 6.83% | 1.22% | 0.69% | 0.95% | 0.97% | -1.29% | -5.70% | -4.82% | 1.90% | 1.35% | 1.03% |
| NM % | 4.00% | 3.49% | 0.50% | -4.40% | -2.36% | 1.85% | 8.19% | 0.79% | 0.18% | 0.87% | 1.16% | -1.69% | -15.17% | -6.77% | 2.85% | 1.60% | 1.41% |
| FCF / R% | 0.00% | -9.94% | -21.86% | -1.36% | -1.46% | 6.58% | 8.65% | -0.61% | 1.00% | 6.92% | 1.19% | -6.62% | -3.32% | -3.58% | -0.35% | 4.86% | -8.57% |
| FCF / NI% | 32.92% | -165.03% | -1,516.31% | 20.93% | 107.77% | 145.54% | 65.68% | -28.12% | 88.61% | 441.06% | 74.45% | 309.32% | 39.77% | 45.35% | -10.17% | 198.87% | -417.38% |
| Operating Margin (OM) | 0.00 | 0.68 | 0.69 | 0.63 | 0.63 | 0.61 | 0.67 | 0.66 | 0.61 | 0.63 | 0.27 | 0.25 | 0.09 | 0.04 | 0.07 | 0.09 | 0.04 |
Per Share
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 12.00 | 10.20 | 1.41 | -12.30 | -6.38 | 5.27 | 24.30 | 2.40 | 0.59 | 2.73 | 3.63 | -5.22 | -47.73 | -17.34 | 6.87 | 3.98 | 3.14 |
| SPS | 300.31 | 292.63 | 284.19 | 279.57 | 270.98 | 285.27 | 296.64 | 305.41 | 322.28 | 311.95 | 314.02 | 309.50 | 314.57 | 256.28 | 241.54 | 249.53 | 222.97 |
| OCPS | 26.38 | 23.93 | 14.22 | 10.02 | 16.93 | 34.49 | 46.85 | 33.82 | 17.11 | 31.63 | 16.01 | -3.30 | -4.47 | 4.71 | 9.77 | 18.21 | -3.09 |
| FCPS | 6.97 | -29.09 | -62.13 | -3.79 | -3.95 | 18.77 | 25.67 | -1.87 | 3.22 | 21.59 | 3.74 | -20.48 | -10.44 | -9.19 | -0.83 | 12.12 | -19.10 |
| BVPS | 379.65 | 370.47 | 368.30 | 351.64 | 347.77 | 363.30 | 397.24 | 406.44 | 401.75 | 400.17 | 406.39 | 396.48 | 344.23 | 328.05 | 330.79 | 343.06 | 346.51 |
Per Share - CAGR
| Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 12.00 | 10.20 | 1.41 | -12.30 | -6.38 | 5.27 | 24.30 | 2.40 | 0.59 | 2.73 | 3.63 | -5.22 | -47.73 | -17.34 | 6.87 | 3.98 | 3.14 |
| CAGR-SPS | 300.31 | 292.63 | 284.19 | 279.57 | 270.98 | 285.27 | 296.64 | 305.41 | 322.28 | 311.95 | 314.02 | 309.50 | 314.57 | 256.28 | 241.54 | 249.53 | 222.97 |
| CAGR-OCPS | 26.38 | 23.93 | 14.22 | 10.02 | 16.93 | 34.49 | 46.85 | 33.82 | 17.11 | 31.63 | 16.01 | -3.30 | -4.47 | 4.71 | 9.77 | 18.21 | -3.09 |
| CAGR-FCPS | 6.97 | -29.09 | -62.13 | -3.79 | -3.95 | 18.77 | 25.67 | -1.87 | 3.22 | 21.59 | 3.74 | -20.48 | -10.44 | -9.19 | -0.83 | 12.12 | -19.10 |
| CAGR-BVPS | 379.65 | 370.47 | 368.30 | 351.64 | 347.77 | 363.30 | 397.24 | 406.44 | 401.75 | 400.17 | 406.39 | 396.48 | 344.23 | 328.05 | 330.79 | 343.06 | 346.51 |